AZN.UK

11,354

+1.01%↑

GSK

1,473

+0.72%↑

INDV

740.5

+1.79%↑

AZN.UK

11,354

+1.01%↑

GSK

1,473

+0.72%↑

INDV

740.5

+1.79%↑

AZN.UK

11,354

+1.01%↑

GSK

1,473

+0.72%↑

INDV

740.5

+1.79%↑

AZN.UK

11,354

+1.01%↑

GSK

1,473

+0.72%↑

INDV

740.5

+1.79%↑

AZN.UK

11,354

+1.01%↑

GSK

1,473

+0.72%↑

INDV

740.5

+1.79%↑

Search

Haleon PLC

Closed

SectorHealthcare

391.5 -0.05

Overview

Share price change

24h

Current

Min

387.1

Max

396.8

Key metrics

By Trading Economics

Income

-254M

231M

Sales

-21M

2.8B

P/E

Sector Avg

24.094

73.239

EPS

0.042

Dividend yield

1.68

Profit margin

8.373

Employees

24,561

EBITDA

-317M

399M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+4.39% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.68%

3.06%

Market Stats

By TradingEconomics

Market Cap

937M

35B

Previous open

391.55

Previous close

391.5

News Sentiment

By Acuity

50%

50%

163 / 386 Healthcare

Haleon PLC Chart

Past performance is not a reliable indicator of future results.

Related News

19 Mar 2025, 07:34 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 Mar 2025, 17:26 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Dispose of Remaining Shareholding in Haleon

27 Feb 2025, 07:43 UTC

Earnings

Haleon Expects Further Growth After Profit Rises

18 Mar 2025, 16:58 UTC

Acquisitions, Mergers, Takeovers

Haleon Intends to Cancel Purchased Ordinary Shares

18 Mar 2025, 16:57 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 Mar 2025, 16:56 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 Mar 2025, 16:56 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 Mar 2025, 16:52 UTC

Acquisitions, Mergers, Takeovers

Haleon Takes Note of Announcement

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: This Is Subject to Customary Closing Conditions

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Bookbuilding Period Will Commence Immediately

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 Mar 2025, 16:48 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18 Mar 2025, 16:47 UTC

Acquisitions, Mergers, Takeovers

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18 Mar 2025, 16:47 UTC

Acquisitions, Mergers, Takeovers

Citigroup: This Represents Approx 7.3% Stake in Haleon

18 Mar 2025, 16:46 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

27 Feb 2025, 10:14 UTC

Market Talk
Earnings

Haleon's EPS Beat Is Reassuring -- Market Talk

27 Feb 2025, 07:58 UTC

Market Talk
Earnings

Haleon's Results Are Consistent -- Market Talk

27 Feb 2025, 07:04 UTC

Earnings

Haleon Sees 2025 Organic Operating Profit Growth Ahead of Organic Rev Growth

27 Feb 2025, 07:04 UTC

Earnings

Haleon Backs Mid-Term Targets

27 Feb 2025, 07:03 UTC

Earnings

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

27 Feb 2025, 07:03 UTC

Earnings

Haleon 2024 EPS 15.7p

27 Feb 2025, 07:03 UTC

Earnings

Haleon 2024 Net Pft GBP1.44B

27 Feb 2025, 07:03 UTC

Earnings

Haleon 2024 Pretax Pft GBP1.91B

27 Feb 2025, 07:02 UTC

Earnings

Haleon To Allocate GBP500M For Buybacks In 2025

27 Feb 2025, 07:02 UTC

Earnings

Haleon Raises Dividend to 4.6p Vs 4.2p

27 Feb 2025, 07:01 UTC

Earnings

Analysts Saw Haleon 2024 Adj Oper Pft Margin at 22.3%

27 Feb 2025, 07:01 UTC

Earnings

Haleon 2024 Adj Oper Pft Margin 22.3%

Peer Comparison

Price change

Haleon PLC Forecast

Price Target

By TipRanks

4.39% upside

12 Months Forecast

Average 407 GBX  4.39%

High 460 GBX

Low 315 GBX

Based on 11 Wall Street analysts offering 12 month price targets forHaleon PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

4

Buy

6

Hold

1

Sell

Sentiment

By Acuity

163 / 386 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.